Patients with age-related macular degeneration may have “transient” adverse macular changes after cataract surgery, but these usually resolve by 6 months later, according to a study published in Ophthalmology Retina.
The data also show no postoperative change in anti-VEGF injections in patients with neovascular AMD.
“The coexistence of AMD and cataracts poses complex management dilemmas for clinicians, particularly concerning the timing and outcomes of cataract surgery in AMD patients,” Leopold Hössl, of the department of ophthalmology at Charité University Medicine Berlin, Germany, and